Multiomic predictors for regression of cirrhosis:Clinical implications and future directions  

作　　者：Binghua Li Decai Yu 

机构地区：[1]Division of Hepatobiliary and Transplantation Surgery,Department of General Surgery,Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School,Nanjing 210008,China

出　　处：《iLIVER》2024年第4期1-2,共2页国际肝胆健康(英文)

基　　金：supported by grants from the National Natural Science Foundation of China(No.82372834 and 82173129).

摘　　要：Advanced chronic liver disease(ACLD)can lead to fibrosis,cirrhosis,and eventually hepatocellular carcinoma(HCC)[1].Hepatic fibrosis is characterized by formation of a fibrous scar because of accumulation of extracellular matrix proteins,predominantly crosslinked type I and type III collagens,which replace the damaged tissue[2].

关 键 词：Cirrhosis regression Multiomics Advanced chronic liver disease BIOMARKER Lipid metabolism 

分 类 号：R73[医药卫生—肿瘤]